Medically prescribed products containing THC have shown value and safety in the management of a number of important clinical conditions, including debilitating chronic pain. Emyria who have seen over 3500 patients upholds evidence-based investigation and pharmacovigilance. Many patients are unfairly prohibited from access to these products by out-of-date driving legislation and testing that is not evidence-based. We need to Drive Change to prohibit driving with impairment, not driving with improvement.
THC improved my life; now, these unjust laws are hurting me.
This is the story of Deborah. Deborah is a mum and an active, productive member of society. She has been suffering from chronic pain for four years. Chronic pain changed her life: Chronic Pain affected the way I exercise and socialise. But the health aspect it had the most significant impact on was my mental […]Read more
Drive Change honoured to have presented to AMCA board on 4/20
The current state of Change It has been three months since the Drive Change campaign held its first Supporters & Stakeholder meeting. At the meeting, the Drive Change team presented why this campaign is crucial for future and existing patients. The team also asked both industry (product producers, importers and suppliers and the industry bodies […]Read more